34 related articles for article (PubMed ID: 27151429)
1. Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.
Kim HJ; Lee J; Lee KB; Sung K; Kim YB; Kim YS
Gynecol Oncol; 2024 Mar; 182():39-44. PubMed ID: 38246045
[TBL] [Abstract][Full Text] [Related]
2. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
Cassidy RJ; Switchenko JM; Cheng E; Jiang R; Jhaveri J; Patel KR; Tanenbaum DG; Russell MC; Steuer CE; Gillespie TW; McDonald MW; Landry JC
Cancer; 2017 Nov; 123(22):4325-4336. PubMed ID: 28759121
[TBL] [Abstract][Full Text] [Related]
3. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemoradiation Therapy Versus Chemotherapy Alone for Resected Oligodendroglioma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Liu K; Liao X; Chen Y; Jiang S
World Neurosurg; 2023 Feb; 170():e37-e44. PubMed ID: 36273731
[TBL] [Abstract][Full Text] [Related]
5. HNF1B polymorphism influences the prognosis of endometrial cancer patients: a cohort study.
Mandato VD; Farnetti E; Torricelli F; Abrate M; Casali B; Ciarlini G; Pirillo D; Gelli MC; Nicoli D; Grassi M; LA Sala GB; Palomba S
BMC Cancer; 2015 Apr; 15():229. PubMed ID: 25885815
[TBL] [Abstract][Full Text] [Related]
6. Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis.
Moreno AC; Zhang N; Verma V; Giordano SH; Lin SH
J Gastrointest Oncol; 2019 Feb; 10(1):74-84. PubMed ID: 30788162
[TBL] [Abstract][Full Text] [Related]
7. Stage IVB endometrial cancer confined to the abdomen: is chemotherapy superior to radiotherapy?
Cirik DA; Karalok A; Ureyen I; Tasci T; Koc S; Turan T; Tulunay G
Eur J Gynaecol Oncol; 2016; 37(2):226-31. PubMed ID: 27172750
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study.
Koskas M; Fournier M; Vanderstraeten A; Walker F; Timmerman D; Vergote I; Amant F
Eur J Cancer; 2016 Jul; 61():52-60. PubMed ID: 27153472
[TBL] [Abstract][Full Text] [Related]
9. Effects of Adjuvant Radiation Plus Chemotherapy on Survival Outcomes in Stage III C Endometrial Cancer According to Histology: Analysis of Data from the Surveillance, Epidemiology, and End Results Database.
Kou J; Yan G; Xiao L; Wei N; Ren H; Xu J
Technol Cancer Res Treat; 2023; 22():15330338231208610. PubMed ID: 37926997
[No Abstract] [Full Text] [Related]
10. Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis.
Winarto H; Ibrahim NAA; Putri YM; Adnan FDSF; Safitri ED
PeerJ; 2022; 10():e14420. PubMed ID: 36438578
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Adjuvant Chemoradiotherapy Versus Chemotherapy Alone for Stage III Endometrial Cancer: A Multicenter Retrospective Study.
Yoo JG; Kim JH; Kim CJ; Lee HN; Song MJ; Park DC; Yoon JH; Kim SI; Hur SY; Lee SJ
Cancer Control; 2022; 29():10732748221115288. PubMed ID: 35848426
[TBL] [Abstract][Full Text] [Related]
12. Subdivision of IIIC Stage for Endometrioid Carcinoma to Better Predict Prognosis and Treatment Guidance.
Wen L; Zhang Y; Chen S; Wang J; Hu W; Zhong G
Front Oncol; 2020; 10():1175. PubMed ID: 32850338
[No Abstract] [Full Text] [Related]
13. Lymph Node Number Predicts the Efficacy of Adjuvant Chemoradiotherapy in Node-Positive Endometrial Cancer Patients.
Lee J; Yu T; Tsai MH
Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32512893
[TBL] [Abstract][Full Text] [Related]
14. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
[TBL] [Abstract][Full Text] [Related]
15. An optical study of drug resistance detection in endometrial cancer cells by dynamic and quantitative phase imaging.
Yao T; Cao R; Xiao W; Pan F; Li X
J Biophotonics; 2019 Jul; 12(7):e201800443. PubMed ID: 30767401
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD133 in endometrial cancer cells and its implications.
Ding DC; Liu HW; Chang YH; Chu TY
J Cancer; 2017; 8(11):2142-2153. PubMed ID: 28819416
[TBL] [Abstract][Full Text] [Related]
17. Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base.
Lester-Coll NH; Park HS; Rutter CE; Corso CD; Young MR; Ratner ES; Litkouhi B; Decker RH; Yu JB; Damast S
Gynecol Oncol; 2016 Jul; 142(1):54-61. PubMed ID: 27151429
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
